Alcohol and atorvastatin interactions
Pro Research Analysisby 
Searched over 200M research papers
Alcohol and Atorvastatin Interaction: Liver and Cognitive Effects
Alcohol and Atorvastatin Increase Liver Inflammation and Injury
Research shows that both alcohol and atorvastatin can cause liver inflammation and injury when used together. This combination increases the expression of inflammatory markers such as NLRP3, IL-1β, and caspase-8, and reduces the antioxidant glutathione in liver tissue, leading to greater liver damage and insulin resistance compared to either substance alone .
Atorvastatin’s Protective Effects Against Alcohol-Induced Liver Damage
Some studies indicate that atorvastatin alone may actually help reduce liver damage caused by alcohol. Atorvastatin can decrease oxidative stress and inflammation in the liver, which are key factors in alcohol-induced liver injury. This suggests that atorvastatin might have a protective effect against some of the harmful impacts of alcohol on the liver .
Cognitive Impairment from Combined Alcohol and Atorvastatin Use
The combination of alcohol and atorvastatin can also negatively affect the brain. This pairing increases inflammation and cell damage in the brain’s frontal cortex, leading to cognitive impairment. Markers such as NLRP3, IL-1β, miRNA155, and caspase-8 are elevated, and there is evidence of neuron and glial cell degeneration .
Acetylsalicylic Acid (Aspirin) May Reduce Harmful Effects
Acetylsalicylic acid (aspirin) has been shown to reduce the harmful effects of alcohol and atorvastatin on both the liver and brain. Aspirin lowers the levels of inflammatory markers and helps protect against liver and cognitive damage caused by the combination of alcohol and atorvastatin El-Kharashi2018Mohamed2022.
Effects on the Intestinal Mucosa
When alcohol and atorvastatin are taken together, especially at high doses, they can cause changes in the intestinal lining. These changes include separation of the epithelial layer, loss of the villi tips, and increased blood flow in the connective tissue. The damage is more severe with higher doses of atorvastatin combined with alcohol .
Atorvastatin and Alcohol in Heart Cells
In heart cells exposed to alcohol, atorvastatin can reduce stress in the endoplasmic reticulum (a part of the cell involved in protein and fat processing), improve cell structure, and enhance lipid metabolism. This suggests that atorvastatin may help protect heart cells from some of the damaging effects of alcohol .
Conclusion
Alcohol and atorvastatin together can increase inflammation and damage in the liver, brain, and intestines, especially at higher doses. However, atorvastatin may also offer some protective effects against alcohol-induced liver and heart cell damage. Aspirin appears to reduce the harmful effects of this combination. Overall, caution is advised when using atorvastatin with alcohol, and protective strategies may be considered to minimize risks.
Sources and full results
Most relevant research papers on this topic
Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats.
Acetylsalicylic acid reduces the hepatotoxic effects of alcohol and atorvastatin by decreasing NLRP3 inflammasome production in rats' livers.
Histological picture of intestinal mucosa of rats after simultaneous administration of atorvastatin and ethyl alcohol.
Atorvastatin and ethanol together can cause changes in intestinal mucosa, with stronger effects in rats receiving 10x higher doses of atorvastatin.
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients
Atorvastatin treatment shows potential in reducing lipid levels in non-alcoholic fatty liver disease patients, potentially offering a new treatment option.
Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
Atorvastatin effectively reduces hepatic steatosis, inflammation, and fibrosis in APOE3-Leiden mice by preventing cholesterol crystal formation and NLRP3 inflammasome activation.
Pharmacokinetic Interaction between Atorvastatin and Omega-3 Fatty Acid in Healthy Volunteers
Atorvastatin and omega-3 fatty acids show a pharmacokinetic interaction in healthy volunteers, with 90% CIs for primary endpoints outside typical bioequivalence ranges.
Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways.
Atorvastatin, a cholesterol-lowering drug, can cause hepatic oxidative stress and apoptosis in mice through MAPKs, mitochondria, and ER-dependent pathways.
DOI